TAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD

No trades
See on Supercharts

TKD fundamentals

TAKEDA PHARMACEUTICAL CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of TKD for the last quarter is 7.35 B EUR, and it's 4.89% higher compared to the previous quarter. The net income of Q2 24 is 575.14 M EUR.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth